{
    "clinical_study": {
        "@rank": "151264", 
        "acronym": "FIDNL", 
        "arm_group": [
            {
                "arm_group_label": "non-obese healthy subjects", 
                "description": "subjects with BMI<25 and no known disease"
            }, 
            {
                "arm_group_label": "post-gastric bypass", 
                "description": "post-obese subjects 12-18 months after Roux-en-Y gastric bypass"
            }, 
            {
                "arm_group_label": "matched control subjects", 
                "description": "Nonobese, healthy subjects of similar age, weight, and gender ratio, than post-bypass subjects"
            }
        ], 
        "brief_summary": {
            "textblock": "8 healthy volunteers, 8 pre-bypass obese subjects, 8 subjects between 12-18 months\n      post-bypass, and  8 subjects matched to the post-bypass patients will be studied after\n      ingestion of two or three different of the following test-meals: A)cream and whey protein\n      B)cream,  whey protein and fructose + 13C6 fructose C)test meal with cream, whey protein,\n      fructose and glucose + 13C6 fructose Their intestinal de novo lipogenesis will be estimated\n      by measuring 13C-palmitate on triglyceride-rich lipoprotein particles associated with apoB48\n      in blood"
        }, 
        "brief_title": "Fructose-induced Intestinal de Novo Lipogenesis", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "condition": "Obesity", 
        "condition_browse": {
            "mesh_term": "Obesity"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age 18-50 years\n\n          -  sex male or female\n\n          -  less than 2 kg body weight change over the past 3 months subjects\n\n        Exclusion Criteria:\n\n          -  antidiabetic and hypolipemic drugs\n\n          -  alcohol consumption >20g/day\n\n          -  severe eating disorders\n\n          -  severe psychological problems\n\n          -  vegetarian diet or other specific diet\n\n          -  consumption of illicit substances\n\n          -  pregnancy\n\n          -  weight gain or weight loss > 1 kg in the last 3 months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "25 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "8 non-obese healthy male and female subjects with BMI <25 8 obese male and female subjects\n        with BMI> 35 8 post-gastric bypass male and female subjects 8 healthy subjects matched to\n        post-gastric bypass subjects for age, gender and weight"
            }
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01792089", 
            "org_study_id": "193/11"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "non-obese healthy subjects", 
                    "post-gastric bypass", 
                    "matched control subjects"
                ], 
                "description": "cream+ whey protein", 
                "intervention_name": "fat+protein meal", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "non-obese healthy subjects", 
                    "post-gastric bypass", 
                    "matched control subjects"
                ], 
                "description": "cream+ whey protein + fructose", 
                "intervention_name": "Fat + protein + fructose meal", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "non-obese healthy subjects", 
                "description": "Cream + whey protein + glucose:fructose mixture", 
                "intervention_name": "Fat+protein+fructose+glucose meal", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "de novo lipogenesis", 
            "fructose", 
            "roux-en-Y gastric bypass", 
            "post-prandial triglycerides"
        ], 
        "lastchanged_date": "June 3, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Lausanne", 
                    "country": "Switzerland", 
                    "state": "VD"
                }, 
                "name": "Centre Hospitalier Universitaire Vaudois"
            }
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_groups": "3", 
        "official_title": "Measure of Intestinal Lipogenesis in Healthy Volunteers and Obese Subjects Before and After Gastroplasty: Modulation by Glucose and Fructose", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Switzerland: Ethikkommission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Measurement of total TG and 13C palmitate in chylomicrons: The sf >20 fraction of post-prandial blood samples will be prepared, and non-chylomicrons, apoB100-containing lipoprotein will be removes by immuno-affinity chromatography using a specific anti-apoB100 antibody", 
            "measure": "Intestinal de novo lipogenesis", 
            "safety_issue": "No", 
            "time_frame": "0-8-hour post-prandial"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01792089"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Lausanne", 
            "investigator_full_name": "Luc Tappy, MD", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Triglyceride will be measured in the chylomicron, VLDL, LDL and HDL fractions of post-prandial blood samples", 
            "measure": "post-prandial triglyceride profile", 
            "safety_issue": "No", 
            "time_frame": "0-8 hour post-prandial"
        }, 
        "source": "University of Lausanne", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Lausanne", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "June 2014"
    }
}